Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease. Tabar V, Sarva H, Lozano AM, Fasano A, et al. Nature 2025 Apr 16. doi: 10.1038/s41586-025-08845.

Read + Share

Amedeo Smart

Independent Medical Education

Tabar V, Sarva H, Lozano AM, Fasano A, et al. Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease. Nature 2025 Apr 16. doi: 10.1038/s41586-025-08845.
PMID: 40240592